Abbvie (ABBV) Reiterated at Overweight by Cantor Fitzgerald on Zumilokibart Promise
Tweet Send to a Friend
Cantor Fitzgerald analyst Carter Gould reiterated an Overweight rating on Abbvie (NYSE: ABBV).The analyst commented, "Durability and mode ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
